National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure

In the majority of these studies, cTnT or cTnI cutoff concentrations were higher than either the 99th percentile or the 10% CV value. These and other studies have consistently shown that postprocedural increases in cTn and/or CK-MB are associated with major adverse clinical events.